Publication:
Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study

dc.contributor.authorJuncal-Ruiz, Maria
dc.contributor.authorRiesco-Davila, Laura
dc.contributor.authorVazquez-Bourgon, Javier
dc.contributor.authorOrtiz-Garcia de la Foz, Victor
dc.contributor.authorMayoral-Van Son, Jacqueline
dc.contributor.authorAyesa-Arriola, Rosa
dc.contributor.authorSetien-Suero, Esther
dc.contributor.authorLeza, Juan Carlos
dc.contributor.authorLopez-Hoyos, Marcos
dc.contributor.authorCrespo-Facorro, Benedicto
dc.date.accessioned2024-10-23T13:07:25Z
dc.date.available2024-10-23T13:07:25Z
dc.date.issued2020-08-25
dc.description.abstractToll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathogenesis of psychosis. The purpose of this work was to compare the expression and functionality of 9 TLRs in three peripheral blood mononuclear cells (PBMCs) (monocytes, B cells, and T cells) between 33 drug-naïve first-episode psychosis (FEP) individuals and 26 healthy volunteers, at baseline and after 3-month of antipsychotic treatment. The expression of TLRs 1-9 were assessed by flow cytometry. For the assessment of the TLR functionality, cells collected in sodium heparin tubes were polyclonally stimulated for 18 h, with different agonists for human TLR1-9. The results of our study highlight the role that TLR5 and TLR8 might play in the pathophysiology of psychosis. We found a lower expression of these receptors in FEP individuals, regarding healthy volunteers at baseline and after 3-month of treatment on the three PBMCs subsets. Most TLRs showed a lower functionality (especially reduced intracellular levels of TNF-α) in patients than in healthy volunteers. These results, together with previous evidence, suggest that individuals with psychosis might show a pattern of TLR expression that differs from that of healthy volunteers, which could vary according to the intensity of immune/inflammatory response.
dc.format.number17es_ES
dc.format.volume21es_ES
dc.identifier.doi10.3390/ijms21176106
dc.identifier.e-issn1422-0067es_ES
dc.identifier.journalInternational journal of molecular scienceses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/16165
dc.identifier.pubmedID32854231es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25286
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCytokines
dc.subjectNeuroinflammation
dc.subjectPsychosis
dc.subjectToll-like receptors
dc.subject.meshAdult
dc.subject.meshAntipsychotic Agents
dc.subject.meshB-Lymphocytes
dc.subject.meshCase-Control Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLeukocytes, Mononuclear
dc.subject.meshMale
dc.subject.meshProspective Studies
dc.subject.meshPsychotic Disorders
dc.subject.meshT-Lymphocytes
dc.subject.meshToll-Like Receptor 5
dc.subject.meshToll-Like Receptor 8
dc.subject.meshYoung Adult
dc.titleExpression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files